| Application no. and date | 13814812.7 (espacenet) (Federated) (European Patent Register), 20131218 | | Patent/reg. no. and date | DK/EP 2935329, 20200916 | | Publication date | 20151028 | | Priority no. and date | US 201261745386 P, 20121221 | | EP pub. no. and date |
EP 2935329 20151028 | | Effective date | | | Applicant/owner | Merck Sharp & Dohme LLC, 126 East Lincoln Avenue
Rahway, New Jersey 07065, US | | Applicant ref. no. | V155780DK | | Inventor | PIERCE, Robert, H., 712 Bryant Street 5
San Francisco, California 94107, US,
BOURNE, Patricia, 901 S. California Avenue
Palo Alto, California 94304, US,
LIANG, Linda, 901 S. California Avenue
Palo Alto, California 94304, US,
BIGLER, Michael, 901 S. California Avenue
Palo Alto, California 94304, US | | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | | Opponent | | | IPC Class | C07K 16/28 (2006.01) , G01N 33/574 (2006.01) , G01N 33/577 (2006.01) | | Title | ANTISTOFFER, DER BINDER TIL HUMAN PROGRAMMERET DØDSLIGAND 1 (PD-L1) | | Int. application no. | US2013075932 | | Int. publication no. | WO2014100079 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
